Amosulalol: Difference between revisions
Appearance
Content deleted Content added
Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB) |
templated cite |
||
Line 52: | Line 52: | ||
}} |
}} |
||
'''Amosulalol''' ([[International Nonproprietary Name|INN]]) is an anti-hypertensive drug. It has much higher affinity for alpha-1 adrenergic receptors than for beta adrenergic receptors.<ref>{{cite book | |
'''Amosulalol''' ([[International Nonproprietary Name|INN]]) is an anti-hypertensive drug. It has much higher affinity for alpha-1 adrenergic receptors than for beta adrenergic receptors.<ref>{{cite book | vauthors = Sponer G, Bartsch W, Hooper RG | chapter = Drugs acting on multiple receptors: β-blockers with additional properties. | title = Pharmacology of antihypertensive therapeutics | date = 1990 | pages = 131–226 (183) | publisher = Springer | location = Berlin, Heidelberg | series = Handbook of Experimental Pharmacology | volume = 93 | doi = 10.1007/978-3-642-74209-5_5 | isbn = 978-3-642-74209-5 | chapter-url = https://archive.org/details/pharmacologyofan0093unse }}</ref> |
||
It is not approved for use in the United States. |
It is not approved for use in the United States. |
Revision as of 07:44, 2 March 2021
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H24N2O5S |
Molar mass | 380.46 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Amosulalol (INN) is an anti-hypertensive drug. It has much higher affinity for alpha-1 adrenergic receptors than for beta adrenergic receptors.[1]
It is not approved for use in the United States.
References
- ^ Sponer G, Bartsch W, Hooper RG (1990). "Drugs acting on multiple receptors: β-blockers with additional properties.". Pharmacology of antihypertensive therapeutics. Handbook of Experimental Pharmacology. Vol. 93. Berlin, Heidelberg: Springer. pp. 131–226 (183). doi:10.1007/978-3-642-74209-5_5. ISBN 978-3-642-74209-5.